We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of a Ultra-sound of the Lung to Diagnose Lung Diseases

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01225367
First Posted: October 21, 2010
Last Update Posted: August 13, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Echosense Ltd.
  Purpose

The study is a prospective open evaluating study of Ultrasound/Doppler application to the chest cavity intended to detect and characterize pathologies of the pulmonary and cardio-vascular system.

The system is a noninvasive non-imaging device designated to monitor flow and movement velocity and display the data continuously.


Condition Intervention
Pulmonary Pathologies Cardio-pulmonary Diseases Device: ultrasound doppler monitoring

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Detection and Characterization of Cardio-pulmonary Patho-physiological States and Diseases by Ultrasound Transthoracic Doppler

Resource links provided by NLM:


Further study details as provided by Echosense Ltd.:

Primary Outcome Measures:
  • Diagnose specific pattern of LDS signals as Power and Velocity in pulmonary diseases in comparison to controls. [ Time Frame: 1 year ]

Enrollment: 120
Study Start Date: August 2010
Study Completion Date: August 2015
Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
pulmonary doppler Device: ultrasound doppler monitoring
Regular noninvasive chest echo monitoring

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
primary care clinic
Criteria

Inclusion Criteria:

  • Age 18y or older
  • patients who are clinically suspected of having a significant pulmonary or cardio-pulmonary disease
  • Patients with CHF
  • Patients with pulmonary hypertension
  • Patients with COPD
  • Patients with Asthma
  • Signed informed consent
  • Normal subjects

Exclusion Criteria:

  • Patients with unstable conditions: unstable angina, uncontrolled CHF, etc
  • Inability to assume a sitting or supine position
  • Patients with severe chest wall deformity
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01225367


Locations
Israel
Elisha hospital
Haifa, Israel, 31064
Sponsors and Collaborators
Echosense Ltd.
Investigators
Principal Investigator: Moshe Person, MD Elisha Hospital
  More Information

Responsible Party: Echosense Ltd.
ClinicalTrials.gov Identifier: NCT01225367     History of Changes
Other Study ID Numbers: ES_DOP05
First Submitted: October 19, 2010
First Posted: October 21, 2010
Last Update Posted: August 13, 2015
Last Verified: May 2011

Additional relevant MeSH terms:
Lung Diseases
Pulmonary Heart Disease
Respiratory Tract Diseases
Heart Diseases
Cardiovascular Diseases